Daily Stock Analysis, XXII, 22nd Century Group Inc, priceseries

22nd Century Group Inc. Daily Stock Analysis
Stock Information
Open
2.10
Close
2.09
High
2.15
Low
2.06
Previous Close
2.11
Daily Price Gain
-0.02
YTD High
3.13
YTD High Date
Jan 3, 2022
YTD Low
1.86
YTD Low Date
Jan 24, 2022
YTD Price Change
-0.91
YTD Gain
-30.33%
52 Week High
6.07
52 Week High Date
Apr 26, 2021
52 Week Low
1.86
52 Week Low Date
Jan 24, 2022
52 Week Price Change
-0.08
52 Week Gain
-3.69%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jun 5. 2017
1.46
Jun 27. 2017
1.75
16 Trading Days
19.84%
Link
LONG
Aug 2. 2017
1.93
Aug 11. 2017
2.06
7 Trading Days
6.99%
Link
LONG
Sep 7. 2017
2.27
Sep 21. 2017
2.89
10 Trading Days
27.09%
Link
LONG
Dec 27. 2017
2.77
Jan 25. 2018
3.57
19 Trading Days
28.83%
Link
LONG
Aug 28. 2018
2.47
Sep 6. 2018
2.60
6 Trading Days
5.32%
Link
LONG
Nov 21. 2018
2.72
Dec 6. 2018
2.91
9 Trading Days
7.08%
Link
LONG
Apr 29. 2019
2.01
May 8. 2019
2.11
7 Trading Days
5.08%
Link
LONG
Aug 8. 2019
1.64
Aug 27. 2019
1.89
13 Trading Days
15.45%
Link
LONG
Dec 17. 2019
1.06
Dec 18. 2019
1.14
1 Trading Days
7.08%
Link
LONG
Dec 23. 2019
1.00
Jan 8. 2020
1.08
10 Trading Days
8.49%
Link
LONG
Nov 13. 2020
0.82
Dec 28. 2020
2.24
29 Trading Days
174.91%
Link
LONG
Feb 2. 2021
2.66
Feb 23. 2021
3.55
14 Trading Days
33.61%
Link
LONG
Apr 19. 2021
3.55
May 3. 2021
4.36
10 Trading Days
22.77%
Link
LONG
Feb 4. 2022
2.17
Feb 11. 2022
2.28
5 Trading Days
5.18%
Link
Company Information
Stock Symbol
XXII
Exchange
NYSE MKT
Company URL
http://www.xxiicentury.com
Company Phone
(716) 270-1523
CEO
Henry Sicignano
Headquarters
New York
Business Address
9530 MAIN STREET, CLARENCE,, NY 14031
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001347858
About

22nd Century Group, Inc. is a plant biotechnology company, which engages in the development of technology that will allow to increase or decrease the level of nicotine and nicotinic alkaloids in tobacco plants and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. Its products include X-22, modified risk cigarettes, spectrum government research cigarettes, magic 0 and magic 2, moonlight, red sun, variable nicotine-level research cigarettes, and verfola. The company was founded on January 25, 2011 and is headquartered in Clarence, NY.

Description

22nd Century Group, Inc., a plant biotechnology company, provides technology that allows for the level of nicotine and other nicotinic alkaloids in tobacco plants to be decreased or increased through genetic engineering and plant breeding. It develops smoking cessation products and modified risk tobacco products for smokers who are unable or unwilling to quit smoking and who may be interested in cigarettes, which reduce exposure to nicotine or to certain tobacco smoke toxins and/or pose a lower health risk than conventional cigarettes. The company's products include RED SUN and MAGIC regular and menthol cigarettes; and SPECTRUM government research cigarettes. It is also developing X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation; and modified risk cigarettes, such as BRAND A, which has approximately 95% less nicotine than conventional tobacco cigarettes, as well as BRAND B cigarettes that contain low amount of tar per milligram of nicotine. 22nd Century Group, Inc. has a scientific collaboration with the University of Virginia; and a strategic partnership with Anandia Laboratories, Inc. The company was founded in 1998 and is headquartered in Clarence, New York.